Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Merck
MRK
|
$446M |
| 2 |
NVIDIA
NVDA
|
$375M |
| 3 |
Apple
AAPL
|
$319M |
| 4 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$317M |
| 5 |
Meta Platforms (Facebook)
META
|
$310M |
Top Sells
| 1 |
SWN
Southwestern Energy Company
SWN
|
$381M |
| 2 |
Exxon Mobil
XOM
|
$324M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
$223M |
| 4 |
SoFi Technologies
SOFI
|
$160M |
| 5 |
VSTO
Vista Outdoor Inc.
VSTO
|
$136M |
Sector Composition
| 1 | Technology | 20.48% |
| 2 | Financials | 18.31% |
| 3 | Industrials | 12.31% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMA
3276
ImageneBio, Inc. Common Stock
IMA
$94.5M
| $63.2K | ﹤0.01% |
3,218
| – | – |
|
3277
Intellicheck
IDN
$105M
| $61K | ﹤0.01% |
21,785
+3,471
| +19% | +$9.72K |
|
3278
iBio
IBIO
$15.9M
| $59.2K | ﹤0.01% |
24,150
+79
| +0.3% | +$194 |
|
3279
MEI Pharma
MEIP
$140M
| $57.6K | ﹤0.01% |
23,427
| – | – |
|
3280
Butterfly Network
BFLY
$385M
| $57.3K | ﹤0.01% |
+18,247
| New | +$57.3K |
|
3281
Babcock & Wilcox
BW
$221M
| $57K | ﹤0.01% |
+34,739
| New | +$57K |
|
3282
Assertio
ASRT
$77.7M
| $56K | ﹤0.01% |
64,304
| – | – |
|
3283
Aprea Therapeutics
APRE
$8.74M
| $56K | ﹤0.01% |
17,064
| – | – |
|
3284
CareCloud
CCLD
$148M
| $55.3K | ﹤0.01% |
15,096
+3,641
| +32% | +$13.3K |
|
3285
BioAtla
BCAB
$29.3M
| $52.6K | ﹤0.01% |
88,953
-86,264
| -49% | -$51K |
|
|
VISL
3286
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
| $52.5K | ﹤0.01% |
13,707
-1,014
| -7% | -$3.88K |
|
3287
Aterian
ATER
$9.51M
| $52.3K | ﹤0.01% |
21,778
| – | – |
|
3288
Lazydays
GORV
$10.4M
| $52.3K | ﹤0.01% |
1,827
-284
| -13% | -$8.12K |
|
3289
Sono-Tek
SOTK
$57.6M
| $51.1K | ﹤0.01% |
12,737
-1,792
| -12% | -$7.19K |
|
3290
Sonim Technologies
SONM
$10.5M
| $50.9K | ﹤0.01% |
16,118
| – | – |
|
|
VXRT
3291
DELISTED
Vaxart
VXRT
| $50K | ﹤0.01% |
75,491
| – | – |
|
|
IMAB
3292
I-MAB
IMAB
$355M
| $49.6K | ﹤0.01% |
58,358
| – | – |
|
3293
Marker Therapeutics
MRKR
$11.1M
| $49.4K | ﹤0.01% |
15,900
-4,378
| -22% | -$13.6K |
|
3294
enVVeno Medical
NVNO
$15.2M
| $49.1K | ﹤0.01% |
16,242
-16,951
| -51% | -$51.2K |
|
3295
Soluna Holdings
SLNH
$14M
| $48.4K | ﹤0.01% |
23,041
+9,264
| +67% | +$19.5K |
|
3296
Sypris Solutions
SYPR
$51.8M
| $48.2K | ﹤0.01% |
27,095
| – | – |
|
3297
Lexicon Pharmaceuticals
LXRX
$389M
| $48K | ﹤0.01% |
64,966
-11,120
| -15% | -$8.21K |
|
3298
OPAL Fuels
OPAL
$64.4M
| $47.9K | ﹤0.01% |
14,126
| – | – |
|
3299
AlTi Global
ALTI
$432M
| $44.4K | ﹤0.01% |
+10,076
| New | +$44.4K |
|
3300
Actinium Pharmaceuticals
ATNM
$52.7M
| $44K | ﹤0.01% |
34,923
-16,361
| -32% | -$20.6K |
|